Total Payments
$1,004
2024 Payments
$158.26
Companies
8
Transactions
34
Medicare Patients
2,460
Medicare Billing
$232,131
Payment Breakdown by Category
Food & Beverage$947.65 (94.3%)
Travel$56.84 (5.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $947.65 | 33 | 94.3% |
| Travel and Lodging | $56.84 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $235.34 | 2 | $0 (2024) |
| Celgene Corporation | $218.59 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $211.74 | 2 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $188.07 | 2 | $0 (2017) |
| Cardiovascular Systems Inc. | $94.05 | 1 | $0 (2021) |
| Olympus America Inc. | $24.43 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $20.26 | 1 | $0 (2022) |
| Shield Therapeutics Inc | $12.01 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158.26 | 3 | ABBVIE INC. ($113.91) |
| 2023 | $398.26 | 24 | Celgene Corporation ($174.24) |
| 2022 | $32.27 | 2 | Merck Sharp & Dohme LLC ($20.26) |
| 2021 | $203.20 | 2 | E.R. Squibb & Sons, L.L.C. ($109.15) |
| 2017 | $212.50 | 3 | BOSTON SCIENTIFIC CORPORATION ($188.07) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: Neuroscience | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $113.91 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Neuroscience | ||||||
| 11/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.17 | General |
| Category: Neuroscience | ||||||
| 10/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.11 | General |
| Category: Neuroscience | ||||||
| 10/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.05 | General |
| Category: Neuroscience | ||||||
| 10/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.40 | General |
| Category: Neuroscience | ||||||
| 10/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: Neuroscience | ||||||
| 10/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.56 | General |
| Category: Neuroscience | ||||||
| 10/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Neuroscience | ||||||
| 09/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.73 | General |
| Category: Neuroscience | ||||||
| 09/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.35 | General |
| Category: Neuroscience | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $102.59 | General |
| Category: Neuroscience | ||||||
| 08/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.13 | General |
| Category: Neuroscience | ||||||
| 08/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.02 | General |
| Category: Neuroscience | ||||||
| 07/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.00 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.88 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.17 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.66 | General |
| Category: Neuroscience | ||||||
| 06/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.34 | General |
| Category: Neuroscience | ||||||
| 06/01/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.02 | General |
| Category: Neuroscience | ||||||
| 06/01/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.38 | General |
| Category: Neuroscience | ||||||
| 05/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Neuroscience | ||||||
| 03/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Neuroscience | ||||||
| 03/27/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.53 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 595 | 623 | $368,492 | $72,236 |
| 2022 | 13 | 795 | 817 | $401,166 | $83,058 |
| 2021 | 13 | 467 | 473 | $200,175 | $36,124 |
| 2020 | 12 | 603 | 616 | $235,206 | $40,713 |
Total Patients
2,460
Total Services
2,529
Medicare Billing
$232,131
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 171 | 171 | $75,150 | $23,339 | 31.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 78 | 78 | $76,830 | $14,391 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 106 | $30,731 | $11,169 | 36.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 92 | 92 | $98,992 | $6,112 | 6.2% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 23 | 23 | $21,620 | $5,943 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 58 | $11,252 | $4,089 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $10,476 | $2,958 | 28.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $29,025 | $2,302 | 7.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $14,416 | $1,933 | 13.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 178 | 178 | $51,622 | $16,024 | 31.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 76 | 76 | $74,860 | $14,366 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $34,839 | $11,675 | 33.5% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 23 | 24 | $22,560 | $6,614 | 29.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 85 | 87 | $93,612 | $6,180 | 6.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 135 | 141 | $17,625 | $5,913 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 50 | $14,603 | $5,516 | 37.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $25,228 | $4,295 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 56 | $10,864 | $4,078 | 37.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 56 | 57 | $38,475 | $3,853 | 10.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $8,624 | $2,824 | 32.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $6,720 | $1,101 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $1,534 | $616.75 | 40.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 34 | 35 | $36,260 | $6,584 | 18.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 53 | 53 | $15,423 | $5,511 | 35.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 23 | 23 | $22,808 | $4,388 | 19.2% |
About Sachin Mohan
Sachin Mohan is a Gastroenterology healthcare provider based in Oxon Hill, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1114269461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sachin Mohan has received a total of $1,004 in payments from pharmaceutical and medical device companies, with $158.26 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($947.65).
As a Medicare-enrolled provider, Mohan has provided services to 2,460 Medicare beneficiaries, totaling 2,529 services with total Medicare billing of $232,131. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Oxon Hill, MD
- Active Since 03/25/2013
- Last Updated 12/13/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114269461
Products in Payments
- ZEPOSIA (Drug) $430.33
- QULIPTA (Drug) $235.34
- GENERAL - THERAPIES (Device) $188.07
- Diamondback Peripheral (Device) $94.05
- Olympus EMR & ESD Devices (Device) $24.43
- VERQUVO (Drug) $20.26
- ACCRUFER (Drug) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oxon Hill
Karen Chachu, Md, MD
Gastroenterology — Payments: $18,849
Gastroenterology $18,849
Dr. Kasra Adham, Md, MD
Gastroenterology — Payments: $5,872
Gastroenterology $5,872
Dr. Jonathan Mccone, M.d, M.D
Gastroenterology — Payments: $4,951
Gastroenterology $4,951
Dr. Eric Lavery, M.d, M.D
Gastroenterology — Payments: $3,742
Gastroenterology $3,742
Dr. Abdulhosein Adham, M.d, M.D
Gastroenterology — Payments: $2,002
Gastroenterology $2,002